Spero Therapeutics, Inc. (NASDAQ:SPRO) Q1 2021 Earnings Conference Call May 6, 2021 4:30 PM ET Company Participants Ashley Robinson - Investor Relations Ankit Mahadevia - Chief Executive Officer David Melnick - Chief Medical Officer Cristina Larkin - Chief Operating Officer Sath Shukla - Chief Financial Officer Conference Call Participants Ritu Baral - Cowen Louise Chen - Cantor Fitzgerald Kevin DeGeeter - Oppenheimer Esther Hong - Berenberg Ram Selvaraju - H.C. Wainwright Operator Greetings and welcome to ...